Focused on positive impact: Ricola becomes a B Corporation
LAUFEN, SWITZERLAND – Newsaktuell – 4 March 2024 – Marking an important milestone on its sustainability journey, Ricola is now a certified B Corporationâ„¢. This […]
Month: March 2024
Berlin Cures’ BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients […]
Sea Limited Reports Fourth Quarter and Full Year 2023 Results
SINGAPORE–(BUSINESS WIRE)–Sea Limited (NYSE: SE) (“Sea†or the “Companyâ€) today announced its financial results for the fourth quarter and full year ended December 31, 2023. […]
Power Restored After Interruption at CSA Copper Mine
ST. HELIER, Jersey–(BUSINESS WIRE)–Metals Acquisition Limited ARBN 671 963 198 (NYSE: MTAL; ASX: MAC) Metals Acquisition Limited ARBN 671 963 198 (NYSE: MTAL; ASX:MAC), a […]
Kao the Sole Japanese and Asian Company Included in the World’s Most Ethical Companies® List for a Record 18th Consecutive Year
TOKYO–(BUSINESS WIRE)–#ESG–The Ethisphere Institute, a leading US think-tank, has named Kao Corporation (TOKYO:4452) one of the World’s Most Ethical Companies. Kao is the sole Japanese […]
Heng An Standard Life (Asia) fully supports Hong Kong new Capital Investment Entrant Scheme with ILAS now available for application
Celebrating our 25 years by introducing the “5N Proposition†to provide customers with comprehensive long-term insurance and wealth management services HONG KONG SAR – Media […]
Hytera Unveils Wearable Two-Way Radio and S Series Product Line
SHENZHEN, China–(BUSINESS WIRE)–#Hytera–Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, proudly introduces its latest innovation: the S Series business […]
HPV Affects Us All – Be Protected and Make It #OneLessWorry
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 4 March 2024 – Human papillomavirus (HPV) is the primary cause of cervical cancer. Despite being a […]
Berlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients […]
AIM Vaccine Enters the Period of Explosive Growth in Major Single Products
Leading the Two Golden Tracks of Pneumonia Vaccine and Rabies Vaccines HONG KONG SAR – Media OutReach Newswire – 4 March 2024 – AIM Vaccine […]
Kaohsiung Draws Potential Investors at Kumamoto Expo
KAOHSIUNG, TAIWAN – Media OutReach Newswire – 4 March 2024 – Headed by Deputy Mayor Lo Ta-sheng, the Kaohsiung delegation to KUMAMOTO Industrial Revitalization EXPO […]
Axelspace’s Demonstration Satellite “PYXIS†Scheduled for Launch
About the launch and the missions of PYXIS TOKYO–(BUSINESS WIRE)–#axelspace–Axelspace Corporation’s (Axelspace) demonstration satellite PYXIS is targeted to launch on March 4, 2024 (PST). Axelspace […]
VeriSilicon’s industry-leading embedded GPU IP powers HPMicro’s high-performance HPM6800 series RISC-V MCU
A new generation of instrumentation dashboard products with high image quality and low power consumption SHANGHAI–(BUSINESS WIRE)–#CameraMonitorSystem–VeriSilicon (688521.SH) today announced that HPMicro’s HPM6800 series, a […]
Europcar Mobility Group Expands in India, With Satguru Travel Becoming Its New Europcar Franchisee
As part of its new strategic framework EXCEED, Europcar Mobility Group reinforces its global footprint thanks to a franchise agreement with Satguru Travel in India, […]
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
Parallel applications based on TROPION-Lung01 and TROPION-Breast01 phase 3 trial results demonstrating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan significantly improved progression-free survival versus chemotherapy in […]